Indaptus Therapeutics Reports FY Financial Results
Thursday, 14 March 2024, 14:09
Indaptus Therapeutics Financial Report
Indaptus Therapeutics recently reported its financial performance for the fiscal year, showing a GAAP EPS of -$1.83. The company disclosed holding $13.4 million in cash and cash equivalents as of December 31, 2023. This financial data reveals the financial challenges that Indaptus Therapeutics is navigating through.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.